scholarly article | Q13442814 |
P356 | DOI | 10.1002/PD.5051 |
P698 | PubMed publication ID | 28406537 |
P50 | author | Alexandros Sotiriadis | Q87826861 |
Elisavet Siomou | Q87826863 | ||
P2093 | author name string | Maria Alexiou | |
Apostolos Athanasiadis | |||
Emmanouil Manolakos | |||
Ioannis Papoulidis | |||
Vasilios Papadopoulos | |||
Makarios Eleftheriades | |||
Elena Papageorgiou | |||
P2860 | cites work | Non-invasive prenatal testing: a review of international implementation and challenges | Q26999426 |
The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. | Q30250029 | ||
Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics | Q34535626 | ||
Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis | Q35552815 | ||
Increased nuchal translucency with normal karyotype | Q36104429 | ||
Limited Clinical Utility of Non-invasive Prenatal Testing for Subchromosomal Abnormalities | Q36473401 | ||
Chromosomal microarray versus karyotyping for prenatal diagnosis | Q36546668 | ||
Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis | Q38091392 | ||
Non-invasive prenatal testing for aneuploidy: current status and future prospects | Q38114375 | ||
ISUOG consensus statement on the impact of non-invasive prenatal testing (NIPT) on prenatal ultrasound practice. | Q38217481 | ||
Changing to NIPT as a first-tier screening test and future perspectives: opinions of health professionals | Q38959581 | ||
Screening for Down syndrome: changing practice of obstetricians | Q39992814 | ||
Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. | Q41235376 | ||
Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice | Q43469221 | ||
Noninvasive prenatal screening or advanced diagnostic testing: caveat emptor | Q47810441 | ||
Diagnostic utility of microarray testing in pregnancy loss. | Q47816511 | ||
American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants | Q50310344 | ||
Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
Committee Opinion No. 640 | Q57254622 | ||
P433 | issue | 6 | |
P304 | page(s) | 583-592 | |
P577 | publication date | 2017-05-23 | |
P1433 | published in | Prenatal Diagnosis | Q15760059 |
P1476 | title | Non-invasive prenatal screening versus prenatal diagnosis by array comparative genomic hybridization: a comparative retrospective study | |
P478 | volume | 37 |
Q48105853 | Application of the BACs-on-Beads™ assay for rapid prenatal detection application of BoBs™ for PND of aneuploidies and microdeletions. |
Q64096371 | Chromosomal Microarray Analysis versus Karyotyping in Fetuses with Increased Nuchal Translucency |
Q49973199 | Prenatal diagnosis by chromosomal microarray analysis |
Search more.